A guide to histomorphological evaluation of intestinal inflammation in mouse models

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 8, 2014, Pages 4557-4576

  Erben, Ulrike ^a   Loddenkemper, Christoph ^b   Doerfel, Katja ^c   Spieckermann, Simone ^a   Haller, Dirk ^d   Heimesaat, Markus M ^a   Zeitz, Martin ^a   Siegmund, Britta ^a   Ku¨hl, Anja A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Pathotres Joint Practice for Pathology   (Germany)

^c Cold Spring Harbor Laboratory ^*  (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Histopathology; Inflammation; Inflammatory bowel disease; Mouse models; Scoring

Indexed keywords

ANIMAL; DISEASE MODEL; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; MOUSE; PATHOLOGY; STANDARDS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; MICE;

EID: 84906966448     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999; 11: 648-656.
2. DeVoss J, Diehl L. Murine models of inflammatory bowel disease (IBD): challenges of modeling human disease. Toxicol Pathol 2014; 42: 99-110.
3. Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci 2012; 105: 263-320.
4. Reimann J, Rudolphi A, Claesson MH. Novel experimental approaches in the study of the immunopathology in inflammatory bowel disease. J Molecular Med (Berl) 1995; 73: 133-140.
5. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-1367.
6. Hoffmann JC, Pawlowski NN, Kuhl AA, Ho¨hne W, Zeitz M. Animal models of inflammatory bowel disease: an overview. Pathobiology 2002; 70: 121-130.
7. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002; 20: 495-549.
8. Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, Gearry R, Goh KL, Hamid S, Khan AG, LeMair AW, Malfertheiner, Ouyang Q, Rey JF, Sood A, Steinwurz F, Thomsen OO, Thomson A, Watermeyer G. World Gastroen- terology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 2010; 16: 112-124.
9. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004.
10. Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastroint Liver Physiol 2009; 296: G135-146.
11. Kuhl AA, Pawlowski NN, Grollich K, Loddenkemper C, Zeitz M, Hoffmann JC. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models. J Leukoc Biol 2007; 81: 168-175.
12. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroen- terology 1990; 98: 694-702.
13. Hoffmann JC, Pawlowski NN, Grollich K, Loddenkemper C, Zeitz M, Ku¨hl AA. Gammadelta T lymphocytes: a new type of regulatory T cells suppressing murine 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis. Int J Colorectal Dis 2008; 23: 909-920.
14. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002; 17: 629-638.
15. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003; 170: 3939-3943.
16. Berg DJ, Davidson N, Kuhn R, Mu¨ller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996; 98: 1010-1020.
17. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-261.
18. Baur P, Martin FP, Gruber L, Bosco N, Brahmbhatt V, Collino S, Guy P, Montoliu I, Rozman J, Klingenspor M, Tavazzi I, Thorimbert A, Rezzi S, Kochhar S, Benyacoub J, Kollias G, Haller D. Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(DeltaARE/WT) mouse model. J Proteome Res 2011; 10: 5523-5535.
19. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999; 10: 387-398.
20. Seidel D, Eickmeier I, Kuhl AA, Hamann A, Loddenkemper C, Schott E. CD8 T cells primed in the gut-associated lymphoid tissue induce immune-mediated cholangitis in mice. Hepa- tology 2014; 59: 601-11.
21. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, Jahn HK, Dunay IR, Moter A, Gescher DM, Schumann RR, Go¨bel UB, Liesenfeld O. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol 2006; 177: 8785-8795.
22. Rausch S, Huehn J, Loddenkemper C, Hepworth MR, Klotz C, Sparwasser T, Hamann A, Lucius R, Hartmann S. Establishment of nematode infection despite increased Th2 responses and immunopathology after selective depletion of Foxp3+ cells. Eur J Immunol 2009; 39: 3066-3077.
23. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Peña AS, Meuwissen SG, Van Rees EP. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998; 114: 385-391.
24. Kitajima S, Takuma S, Morimoto M. Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis. J Vet Med Sci 1999; 61: 67-70.
25. Ostanin DV, Pavlick KP, Bharwani S, D'Souza D, Furr KL, Brown CM, Grisham MB. T cell-induced inflammation of the small and large intestine in immunodeficient mice. Am J Physiol Gastrointest Liver Physiol 2006; 290: G109-119.
26. McSorley HJ, Hewitson JP, Maizels RM. Immunomodulation by helminth parasites: defining mechanisms and mediators. Int J Parasitol 2013; 43: 301-310.
27. Deheragoda MG, Baithun S. Omental deposits of fetal parts as a sequal to salpingectomy for ruptured ectopic pregnancy. Histopathology 2006; 49: 426.
28. Stange J, Hepworth MR, Rausch S, Zajic L, Ku¨hl AA, Uyttenhove C, Renauld JC, Hartmann S, Lucius R. IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-gamma at the cost of Th17-driven immunopathology. J Immunol 2012; 188: 2410-2418.
29. Schultz M, Tonkonogy SL, Sellon RK, Veltkamp C, Godfrey VL, Kwon J, Grenther WB, Balish E, Horak I, Sartor RB. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol 1999; 276: G1461-1472.
30. Wirtz S, Finotto S, Kanzler S, Lohse AW, Blessing M, Lehr HA, Galle PR, Neurath MF. Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens. J Immunol 1999; 162: 1884-1888.
31. Fuss IJ, Boirivant M, Lacy B, Strober W. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J Immunol 2002; 168: 900-908.
32. van Driel B, Liao G, Romero X, O'Keeffe MS, Wang G, Faubion WA, Berger SB, Magelky EM, Manocha M, Azcutia V, Grisham M, Luscinskas FW, Mizoguchi E, de Waal Malefyt R, Reinecker HC, Bhan AK, Wang N, Terhorst C. Signaling lymphocyte activation molecule regulates development of colitis in mice. Gastroenterology 2012; 143: 1544-1554, e1547.
33. Shalapour S, Deiser K, Kuhl AA, Glauben R, Krug SM, Fischer A, Sercan O, Chappaz S, Bereswill S, Heimesaat MM, Loddenkemper C, Fromm M, Finke D, Ha¨mmerling GJ, Arnold B, Siegmund B, Schu¨ler T. Interleukin-7 links T lymphocyte and intestinal epithelial cell homeostasis. PLoS One 2012; 7: e31939.
34. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993; 5: 1461-1471.
35. Leithauser F, Krajina T, Trobonjaca Z, Reimann J. Early events in the pathogenesis of a murine transfer colitis. Pathobiology 2002; 70: 156-163.
36. Wei B, Velazquez P, Turovskaya O, Spricher K, Aranda R, Kronenberg M, Birnbaumer L, Braun J. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A 2005; 102: 2010-2015.
37. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
38. Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 2010; 12: 319-330.
39. Karam SM. Lineage commitment and maturation of epithelial cells in the gut. Front Biosci 1999; 4: D286-298.
40. Mcmanus JF. Histological demonstration of mucin after periodic acid. Nature 1946; 158: 202.
41. Jenkins D, Balsitis M, Gallivan S, Dixon MF, Gilmour HM, Shepherd NA, Theodossi A, Williams GT. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997; 50: 93-105.
42. Jenkins D, Goodall A, Scott BB. Simple objective criteria for diagnosis of causes of acute diarrhoea on rectal biopsy. J Clin Pathol 1997; 50: 580-585.
43. Ryan GB, Cliff WJ, Gabbiani G, Irle´ C, Montandon D, Statkov PR, Majno G. Myofibroblasts in human granulation tissue. Hum Pathol 1974; 5: 55-67.
44. Schlingemann RO, Rietveld FJ, Kwaspen F, van de Kerkhof PC, de Waal RM, Ruiter DJ. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol 1991; 138: 1335-1347.
45. Goldgraber MB. Pseudopolyps in ulcerative colitis. Dis Colon Rectum 1965; 8: 355-363.
46. Mahler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, Elson CO, Sundberg JP. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 1998; 274: G544-551.
47. Bansemir AD, Sukhdeo MV. The food resource of adult Heligmosomoides polygyrus in the small intestine. J Parasitol 1994; 80: 24-28.
48. Urban JF Jr, Madden KB, Svetic A, Cheever A, Trotta PP, Gause WC, Katona IM, Finkelman FD. The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev 1992; 127: 205-220.
49. Gause WC, Urban JF Jr, Stadecker MJ. The immune response to parasitic helminths: insights from murine models. Trends Immunol 2003; 24: 269-277.
50. Matsumoto S, Okabe Y, Setoyama H, Takayama K, Ohtsuka J, Funahashi H, Imaoka A, Okada Y, Umesaki Y. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 1998; 43: 71-78.
51. Schaefer JS, Montufar-Solis D, Nakra N, Vigneswaran N, Klein JR. Small intestine inflammation in Roquin-mutant and Roquin-deficient mice. PLoS One 2013; 8: e56436.